A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 204 participants.

Also called NCT07156500

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 204 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07156500
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07156500. Randomized; quadruple masking; primary purpose treatment. Start 2025-09-30 (anticipated); primary completion 2027-03-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone
Intervention (Drug)
HS-20094 Injection
Intervention (Drug)
HS-20094 Placebo Injection
Intervention (Drug)
HS-20094 Injection
Intervention (Drug)
HS-20094 Placebo Injection
Lead sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct07156500
Content hash
6825a50372fb8b200041d8fd7c1b097219e3ed7e3ed774cf695280ce8fc04246